Skip Ribbon Commands
Skip to main content
Sign In

Pages :lUse SHIFT+ENTER to open the menu (new window).Open MenuOpen Menu
This system library was created by the Publishing feature to store pages that are created in this site.

  
  
  
Synonyms, Keywords
Test Components
25001LACOSOLacosamide (LACO)
​Vimpat
22724LDH-OLactate Dehydrogenase, Other Body Fluids
Body Fluid LDH​
22811LDHLactate Dehydrogenase, Total
LD, LDH​
23146LACT-ALactate, Arterial
Lactic Acid (arterial), L-Lactate, LA​
25605LACA0HLactate, Arterial, 0 Hr, Sepsis
​Lactic Acid (arterial), L-Lactate, LA, Sepsis, Protocol
22812LAC-CSFLactate, CSF
Lactic Acid, CSF, L-Lactate, CSF​
22722LACTLactate, Venous
Lactic Acid, Venous, L-Lactate, LA​
25604LACV0HLactate, Venous, 0 Hr, Sepsis
​Lactic Acid, Venous, L-Lactate, LA, Sepsis, Protocol
24971FLACTSOLactoferrin, Fecal, Quantitative (123016)
Fecal Lactoferrin
Fecal Leukocytes
IBD-Scan®
Stool Lactoferrin
The quantitative measurement of fecal lactoferrin released from leukocytes.
22813LTTLactose Tolerance
LTT​
22814LAMOLamotrigine
Lamictal​
22817LDL-DLDL Cholesterol, Direct
Lipoprotein, LDL - Direct, Cholesterol, LDL - Direct, Direct LDL​
22822LEADUSOLead, 24 Hour, Urine (PBU)
Lead (Pb), Pb (Lead) 
22819BLLead, Blood
Pb, Lead in blood​
22820CBLLead, Capillary Blood
Pb - capillary, Lead in blood - capillary​
22823LEGABSOLegionella Antibody Panel (SLEG)
LDA (Legionnaires' Disease Antibody), Legionnaire's Disease
22824LEG-AGLegionella Antigen, Urine
25047LEGPSOLegionella species, PCR (LEGRP)
Fluoribacter bozemanae
Fluoribacter dumoffii
Legionella
Legionella sp
Legionella spp
Legionella bozemanae
Legionella dumoffii
Legionella gormanii
Legionella hackeliae
Legionella jordanis
Legionella longbeachae
Legionella micdadei
Legionella oakridgensis
Legionella pneumophila
Legionella wadsworthii
Legionellosis
Legionnaires disease
25103LEPTNSOLeptin (500237)
25642MISCLeptospira, IgM, Serum (LEPDT)
​L. biflexa, Leptospirosis
24887LEVELevetiracetam, Serum
Keppra, Leviteracetam​
22826LH-RHLH-RH Stimulation Study
22827LIDLidocaine, Serum
Xylocaine​
26089LIDOSOLidocaine, Serum (LID)
Lidocaine (Xylocaine)
22829LIPLipase
22828LIP-OLipase, Other Body Fluid
Body Fluid Lipase​
26123MISCLipoprotein (a), Serum (LIPA1)
Lipoprotein (a), S
Lipoprotein a
Lp(a) apoprotein
LP "little-A"
22831HDLTCLipoprotein Cholesterol and HDL
Cholesterol, Total and HDL, HDL Cholesterol and Total Cholesterol​
Includes total cholesterol, HDL-cholesterol, and calculated non-HDL cholesterol.​
22922BLIPOLipoprotein Panel, Basic
Includes Total Cholesterol, HDL Cholesterol, Triglyceride, calculated LDL Cholesterol and non-HDL Cholesterol.​
23101LIPOBLipoprotein Panel, No LDL
Includes Total Cholesterol, HDL Cholesterol, and Triglyceride.​
22832LIPOCLipoprotein Panel, With LDL
​Lipo, Lipid Profile, Fasting Lipid Profile
​This panel includes measured Total Cholesterol, HDL Cholesterol, and Triglycerides. It also includes calculations for LDL Cholesterol and non-HDL Cholesterol.
22834LILithium
​Li
22835LIVERLiver Panel
​Hepatic Function Panel
​Albumin, Alkaline Phosphatase, Alanine Amino Transferase, Aspartate Amino Transferase, Conjugated Bilirubin, Total Bilirubin, and Total Protein
25302LKM1Liver-Kidney-Microsome-1 Antibodies, IgG
LKM, LKM1, Autoimmune hepatitis type 2
22836MISCLorazepam  (64)
Ativan®​
22837MISCLSD Screen, Urine  (071159)
Lysergic Acid Diethylamide​
26088LNGPRSOLung Cancer-Targeted Gene Panel with Rearrangement, Tumor (LNGPR)
EGFR
BRAF
KRAS
HRAS
NRAS
ERBB2
MET
ALK
ROS1
RET
NTRK1
Lung cancer panel
Lung cancer rearrangement
Lung cancer fusion
Lung panel
Lung tumor panel
Tumor panel
Oncology panel
Next Gen Sequencing Test
NGS

This test uses targeted next-generation sequencing to evaluate for somatic mutations within the EGFR, BRAF, KRAS, HRAS, NRAS, ALK, ERBB2, and MET genes. Next-generation sequencing is also used to identify rearrangements (fusions) involving ALK, ROS1, RET, and NTRK1.

When this test is ordered, slide review will always be performed at an additional charge.

22841LAPANLupus Anticoagulant Panel
Lupus Inhibitor Work-up, Lupus Inhibitor Panel​
Dilute Russell Viper Venom Time (DRVVT), PTT-Lupus Anticoagulant (PTT-LA)​
22842LHLuteinizing Hormone (LH)
26223LHPEDSOLuteinizing Hormone (LH), Pediatrics, Serum (LHPED)

​Third Generation LH assay

Ultrasensitive LH assay

Lutropin

26063LNBABSOLyme CNS Infection, IGG with Antibody Index Reflex (LNBAB)
Neuroinvasive Lyme Disease, Neuroborreliosis, Lyme Disease in the Central Nervous System, Lyme CNS Disease

Lyme CNS Infection IgG Screen

Reflex test: Lyme CNS Infection, IgG

25226LYMPANLyme Disease Serology, Serum
​Lyme Disease, Borrelia burgdorferi, Lyme EIA IgG and IgM, LYMSCR 
​An EIA screen test will be performed on all specimens.  All specimens with a positive or equivocal screening result will reflex to Lyme Confirmatory IB, which will include both IgM and IgG immunoblot.  No immunoblot analysis willl be performed on samples with a negative EIA screening result.
25229LYIBGLyme Immunoblot, IgG
Lyme Immunoblot, IgG, Lyme Western Blot IgG
25227LYIBMLyme Immunoblot, IgM
​Lyme Immunoblot, IgM, Lyme Western Blot, IgM (LYBL-M)
25228LYIBMGLyme Immunoblot, IgM, IgG
​Lyme Immunoblot IgM. Lyme Immunoblot IgG, Lyme Western Blot IgM, Lyme Western Blot IgG
22382LYMEPCRLyme Test by PCR
​Lyme Disease PCR, Borrelia burgdorferi by PCR
26274LPAGFSOLymphocyte Proliferation to Antigens, Blood (LPAGF)

​Blastogenesis Antigens
Immune Competence
Lymphocyte Blastogenesis Antigen
Lymphocyte Phytohemagglutiin
Lymphocyte Transformation

If insufficient peripheral blood mononuclear cells (PBMCs) are isolated from the patient's sample due to low WBC counts or specimen volume received, selected dilutions or stimulants may not be tested at the discretion of the laboratory to ensure the most reliable results. Testing with 1 stimulant will always be performed. When adequate specimen is available for both stimulants to be tested, an additional test ID will be reflexed and billed separately.

25231HMISCLynch Syndrome DNA Mismatch Repair Proteins by IHC
Lynch Syndrome, Immunohistochemistry, IHC, DNA, HNPCC, Microsatellite Instability (MSI), Mismatch Repair Proteins, MMRP, hMLH-1, hMSH-2, hMSH-6, PMS2, Surgical and Histology.
hMLH-1, hMSH-2, hMSH-6, and PMS2
26216LSDSMSOLysosomal Storage Disorders Screen, Random, Urine (LSDS)

Alpha-Fucosidosis,  Alpha-Galactosidase Deficiency,  Alpha-Mannosidosis,  Alpha-N-Acetylgalactosaminidase Deficiency,  Arylsulfatase A Deficiency,  Arylsulfatase B Deficiency,  Aspartylglucosaminuria,  Aspartylglycosaminuria,  Beta-Galactosidase Deficiency,  Beta-Glucuronidase Deficiency,  Ceramide Hexosides,  Ceramide Trihexosidase,  Ceramide Trihexosidase Deficiency,  Chondroitin-6-sulfate,  Chondroitin-6 sulfate,  Dermatan Sulfate,  Diffuse Angiokeratoma,  Fabry Disease,  Fabry's Disease,  GAGS (Glycosaminoglycans),  Galactose-6-Sulfatase Deficiency,  Galactosialidosis,  GB3,  GL3,  Globotriaosylceramide,  Glycosaminoglycans (GAGS),  GM1 gangliosidosis,  GM2 gangliosidosis,  Heparan Sulfate,  Hunter Syndrome,  Hurler Syndrome,  Hurler-Scheie Syndrome,  I-Cell Disease,  Iduronate Sulfatase Deficiency,  Iduronidase Deficiency,  Keratan Sulfate,  LSD,  Lysosomal Storage,  Lysosomal Storage Disease,  Maroteaux Lamy Syndrome,  Maroteaux-Lamy Syndrome,  Metachromatic Leukodystrophy,  Morquio A,  Morquio B,  MPS I,  MPS II,  MPS III,  MPS IVA,  MPS IVB,  MPS VI,  MPS VII,  Mucolipidosis II,  Mucolipidosis III,  Mucopolysaccharides,  Mucopolysaccharidosis,  Multiple Sulfatase Deficiency,  Oligosaccharides,  Oligosaccharidosis,  Pompe Disease,  Pseudo-Hurler Polydystrophy,  Sandhoff Disease,  Sanfilippo Syndrome,  Scheie Syndrome,  Schindler Disease,  Sialidosis,  Sly Syndrome,  Sphingolipids,  Sulfatides​

This is a general urine screening test for a broad array of lysosomal storage (LSD) and related disorders. Not all LSDs are detectable by this method.

Highlights:

The first step in a diagnostic workup of an individual suspected of having a lysosomal storage disorder (LSD) includes urine analyses for metabolites associated with mucopolysaccharidoses, oligosaccharidoses, disorders of sulfatide degradation, and LSDs with characteristic urine profiles.

This test contains a combined analysis of ceramide trihexosides, mucopolysaccharides, oligosaccharides, and sulfatides. This combined analysis of these disease-specific markers allows for the identification of disorders that may not be picked up using any of the single tests alone.

22684LYSOLysozyme, Plasma (MURA)
Muramidase